Last week, citing financial difficulties as the main factor behind their decision, U.S. based Geron corporation announced that it was suspending the world’s first human trial for cells derived from human embryos and getting out of the embryonic stem cell (ESC) research business altogether. In recent years private investment into ESC research has been steadily declining for several reasons, not … Continue reading Geron, Embryonic Stem Cell Research and Your Tax Dollars